152 related articles for article (PubMed ID: 27760866)
1. Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer.
Li Q; Wang K; Su C; Fang J
Technol Cancer Res Treat; 2017 Aug; 16(4):440-445. PubMed ID: 27760866
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer.
Xie H; Guo JH; An WM; Tian ST; Yu HP; Yang XL; Wang HM; Guo Z
World J Gastroenterol; 2017 Mar; 23(12):2159-2167. PubMed ID: 28405143
[TBL] [Abstract][Full Text] [Related]
3. The Diagnostic Value of Serum L1CAM in Patients With Colorectal Cancer.
Chu LY; Guo DM; Chen JT; Fang WK; Xie JJ; Peng YH; Xu YW; Li XX
Technol Cancer Res Treat; 2020; 19():1533033820920971. PubMed ID: 32356487
[TBL] [Abstract][Full Text] [Related]
4. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
5. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
7. Association between serum angiopoietin-2 concentration and clinicopathological parameters in patients with colorectal cancer.
Wang ZQ; Sun XL; Su HL; Liu XF; Xuan YJ; Yu SQ
Genet Mol Res; 2015 Dec; 14(4):15547-52. PubMed ID: 26634521
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
9. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
Chang YT; Huang MY; Yeh YS; Huang CW; Tsai HL; Cheng TL; Wang JY
PLoS One; 2016; 11(10):e0163264. PubMed ID: 27701415
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
[TBL] [Abstract][Full Text] [Related]
13. Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer.
Fung KY; Priebe I; Purins L; Tabor B; Brierley GV; Lockett T; Nice E; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Burgess A; Cosgrove LJ
Cancer Biomark; 2013; 13(2):75-9. PubMed ID: 23838135
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
15. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
[TBL] [Abstract][Full Text] [Related]
16. [Validation and Evaluation of Diagnostic Efficiency of Genes Associated with Colorectal Cancer with Hyperglycemia].
Cui G; Feng WM; Zhang T; Zhu GL; Shi QL; Zhang XL; Xia H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):769-777. PubMed ID: 30606387
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B
Int J Colorectal Dis; 2007 Jan; 22(1):33-8. PubMed ID: 16520929
[TBL] [Abstract][Full Text] [Related]
18. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases.
Zhu CB; Wang CX; Zhang X; Zhang J; Li W
Int J Cancer; 2011 Feb; 128(3):617-22. PubMed ID: 20473865
[TBL] [Abstract][Full Text] [Related]
19. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
20. Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers.
Danese E; Montagnana M; Minicozzi AM; De Matteis G; Scudo G; Salvagno GL; Cordiano C; Lippi G; Guidi GC
Clin Chem Lab Med; 2010 Nov; 48(11):1665-8. PubMed ID: 20704532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
